Navigation Links
Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
Date:10/21/2008

er's disease.

About Alzheimer's Disease

AD is a progressive brain disorder that gradually destroys a person's memory and ability to learn, reason, make judgments, communicate and carry out daily activities. AD is characterised by the progressive destruction of brain cells leading to a decline in mental function and eventually, Alzheimer patients need complete care.

Current estimates show that approximately four million people suffer from AD in the US and 15 million worldwide. Most available treatments produce an increase of the acetylcholine levels by inhibiting AChE, the enzyme responsible for its breakdown. Currently used therapies have significant side-effects which can occur with a frequency of up to 50% for nausea for instance. These treatments generally require complicated titration schemes in order to minimise these cholinergic side-effects, which is a challenge when dealing with memory deficient patients.

An AChE inhibitor with a better tolerance profile than existing treatments and with an easierdosing schedule could improve patient compliance and therefore optimise the patient's treatment.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. It develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed three products with global combined sales in excess of $2.65 billion in 2007.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com'/>"/>

SOURCE The Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Raptor Pharmaceuticals Announces Phase 2a Clinical Trial Initiation in Non-Alcoholic Steatohepatitis (NASH)
2. Multi-Centre European Clinical Trial Shows Advanced Dysplasia and Early Cancer of Esophagus Cured With Combined Endoscopic Resection and Radiofrequency Ablation With HALO Ablation System
3. CeNeRx BioPharma Initiates Phase II Clinical Trial of Its Novel Antidepressant Agent Tyrima(TM)
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
6. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
8. Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
9. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
10. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
11. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... for Medical Devices in the US Market ... Changing Regulatory and Reimbursement Scenario ...   Summary ...
(Date:5/21/2013)... REDWOOD CITY, Calif. , May 21, ... ACRX ), a specialty pharmaceutical company ... innovative therapies for the treatment of acute ... demonstrating that in a placebo-controlled Phase 3 ... PCA (patient-controlled analgesia) System (NanoTab System), the ...
(Date:5/21/2013)... and HENDERSONVILLE, N.C. , May ... procurement program for home medical equipment is forcing ... Carolina to lay off employees or close ... of service and products received by Medicare beneficiaries, says ... defective and dangerous program, the Centers for Medicare ...
Breaking Medicine Technology:Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 2Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 3Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 2Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 3Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 4Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 5Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 6Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 7Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 8Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 9Top-line Data Demonstrate Primary Endpoint Achieved in Final Pivotal Phase 3 Study of Sufentanil NanoTab PCA System For Management of Post-Operative Pain 10North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 2North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 3North Carolina Business Owners At Risk Because Of Defective Medicare Bidding Program 4
... Pharmaceuticals, a leading provider of contract manufacturing services ... multi-year contract-manufacturing agreement with an undisclosed biotechnology company. ... of a sterile liquid product used in processing ... of JHP noted, “We look forward to serving ...
... Cosmetic dentist in Torrance , Dr. Robert Mondavi, DDS, ... provide a safe and comfortable visit for area patients. ... revolutionizing dental examinations. The digital x-ray systems are used ... dental problems at or below the gum line. Early ...
Cached Medicine Technology:JHP Pharmaceuticals Announces Multi-Year Contract Manufacturing Agreement 2Torrance Dentist, Dr. Robert Mondavi, Now Uses Digital X-Rays for Comfort and Safety of the Patients 2
(Date:5/21/2013)... May 21, 2013 Diversity Focus, a ... environments for all residents in the Creative Corridor region, ... Survey at a news conference on Thursday, May 23rd ... study, conducted in 2008. , The survey ... lead and support efforts that attract, nurture and retain ...
(Date:5/21/2013)... Healing Center announces their participation in the CannaCommunity Solutions ... including MedMar Healing Center, doctors, and clubs, are coming together ... raise food to help area kids who have been impacted ... , “We like being able to give back to ... of MedMar Healing Center. “Taking part in the food drive ...
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... 2013) Research into genetic features of pulmonary fibrosis ... School of Medicine may lead to improved treatment of ... online by JAMA . , The study found ... some cases of pulmonary fibrosis, a chronic progressive disease ... result of the study, researchers may want to consider ...
(Date:5/21/2013)... agency for scientific and technological research So Paulo Research ... announced an investment estimated in US$ 680 million to ... a period of up to eleven years, subject to ... , Funding for the 17 RIDCs will come from ... support personnel, and infrastructure). Host institutions will participate in ...
Breaking Medicine News(10 mins):Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2
... stress disorder (PTSD) can occur in civilians, too and ... new review article in the Journal of the American ... a type of anxiety disorder that occurs after a person ... 20 to 51 percent of patients with an orthopaedic injury. ...
... present, it can take up to a year before a ... are diffuse and are often mistaken for other diseases. However, ... whether someone has the disease or not", says Christer Wingren, ... The test can also determine how far the disease has ...
... Seven out of ten hospital nurses who took part in ... administer intramuscular injections - despite the potential risks of sciatic ... hip site recommended by the nursing literature. ... the Journal of Advanced Nursing , found that younger, ...
... News) -- People at risk for celiac disease ought to ... symptoms, a new study suggests. Celiac disease is a ... the person consumes gluten, a protein found in wheat, rye ... has grown rapidly in recent decades, but, according to the ...
... May 9 (HealthDay News) -- Some adults with attention-deficit/hyperactivity ... everyday situations, a combination that appears to run in ... Hospital study that included 83 participants -- 23 with ... (DESR), 33 with neither condition -- plus their siblings. ...
... children taken to hospital emergency departments (EDs) for a head ... parents, concerns. Yet true traumatic brain injury is uncommon. A ... head trauma, led by Children,s Hospital Boston and UC Davis, ... use of head CT by as much as half without ...
Cached Medicine News:Health News:Post-traumatic stress disorder common following significant orthopedic trauma 2Health News:Post-traumatic stress disorder common following significant orthopedic trauma 3Health News:New test could give SLE patients a more tolerable life 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 2Health News:Most nurses don't use recommended intramuscular injection site despite potential risks 3Health News:More People May Benefit From Going Gluten-Free 2Health News:ADHD With Poor Emotional Control Seems to Run in Families 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 2Health News:Large study finds CT scans are frequently unnecessary after head injury in children 3
... a high throughput primary or backup ... offers performance and reliability equal to ... instruments. The advanced technology of the ... strips delivers reproducible and accurate results, ...
... for the World Health Organization as a ... been widely used in clinical trials and ... methods. Urine samples are diluted in buffer ... (enzyme labelled immunoassay with magnetic second antibody ...
... Estrone Enzyme Immunosorbent Assay (EIA) Kit ... of Estrone in serum. The procedure ... immunoassay where there is competition between ... antigen for a fixed number of ...
... Helmer presents the ... with innovative solutions for ... more sophisticated features than ... Bank Refrigerators are at ...
Medicine Products: